Home › Funds › MONIMUS CAPITAL MANAGEMENT, LP › VKTX

MONIMUS CAPITAL MANAGEMENT, LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

MONIMUS CAPITAL MANAGEMENT, LP reported holding 66,502 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.60% of its reported portfolio and ranking #48 among its reported holdings. MONIMUS CAPITAL MANAGEMENT, LP has disclosed VKTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)66.50K sh
Reported value held$2.59M
Portfolio Weight0.60%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONIMUS CAPITAL MANAGEMENT, LP's VKTX position evolved

MONIMUS CAPITAL MANAGEMENT, LP first disclosed a stake in VKTX in Q4 2024 at 21,006 shares (US$845K). The position peaked in Q2 2026 at 66,502 shares, worth US$2.6M. Across 7 filings, MONIMUS CAPITAL MANAGEMENT, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 66,502 shares valued at US$2.6M — a reduction of -1,339 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2025 (shares rose 34% over the following quarter), a 62% trim in Q4 2025 (shares fell 8% over the following quarter), a 493% increase in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 21.01K $845.28K New
Q1 2025 22.64K $546.83K Add
Q2 2025 23.53K $623.60K Add
Q3 2025 29.98K $787.80K Add
Q4 2025 11.44K $402.53K Reduce
Q1 2026 67.84K $2.21M Add
Q2 2026 66.50K $2.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has MONIMUS CAPITAL MANAGEMENT, LP held VKTX?

MONIMUS CAPITAL MANAGEMENT, LP has disclosed VKTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is MONIMUS CAPITAL MANAGEMENT, LP's current position in VKTX?

As of Q2 2026, MONIMUS CAPITAL MANAGEMENT, LP holds 66.50K shares of VKTX (VIKING THERAPEUTICS INC), valued at $2.59M, representing 0.60% of its reported portfolio and ranking #48.

Has MONIMUS CAPITAL MANAGEMENT, LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), MONIMUS CAPITAL MANAGEMENT, LP reduced its position in VKTX. The position peaked in Q2 2026 at 66.50K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.